At the June 16 virtual information session, the LymeX team presented an in-depth overview of the LymeX Diagnostics Prize and answered questions.
The LymeX Diagnostics Prize is a competition to accelerate the development of Lyme disease diagnostics. The $1 million Phase 1 calls on scientific, technical, and clinical experts to submit innovative methods for detecting active Lyme disease infections in people. The ultimate goal of the multiphase competition is to nurture the development of these diagnostics toward Food and Drug Administration review. The competition anticipates awarding up to $10 million in prizes across all potential phases, subject to availability of funds.
To learn more, visit LymeXDiagnosticsPrize.com.